GROUP ONE TRADING, L.P. - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 87 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2013. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$53,000
-11.7%
11,460
+93.2%
0.00%
Q3 2018$60,000
-1.6%
5,931
-30.1%
0.00%
-100.0%
Q2 2018$61,000
-51.6%
8,486
-40.2%
0.00%0.0%
Q3 2017$126,000
-55.9%
14,196
-20.6%
0.00%
-75.0%
Q1 2016$286,000
+61.6%
17,882
+318.3%
0.00%
+33.3%
Q1 2014$177,000
+185.5%
4,275
+167.2%
0.00%
+200.0%
Q4 2013$62,0001,6000.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q4 2013
NameSharesValueWeighting ↓
Orbimed Advisors 5,406,844$52,014,0000.66%
ETF MANAGERS GROUP, LLC 282,268$3,255,0000.24%
Mirae Asset Global Investments Co., Ltd. 1,470,996$14,151,0000.19%
Financial Gravity Companies, Inc. 4,467$42,0000.05%
GSA CAPITAL PARTNERS LLP 67,200$646,0000.04%
TCI Wealth Advisors, Inc. 7,766$75,0000.03%
Freedom Investment Management, Inc. 64,741$623,0000.03%
GAM Holding AG 83,940$808,0000.02%
SFMG, LLC 11,994$115,0000.02%
SHELL ASSET MANAGEMENT CO 95,127$915,0000.02%
View complete list of INSYS THERAPEUTICS INC NEW shareholders